Frese Jr et al., 1994 - Google Patents
Targeting of genes to the liver with glycoprotein carriersFrese Jr et al., 1994
- Document ID
- 1387261535115098778
- Author
- Frese Jr J
- Wu C
- Wu G
- Publication year
- Publication venue
- Advanced drug delivery reviews
External Links
Snippet
Several techniques are available to deliver foreign genes to cells in vitro. These techniques have offered valuable insights into gene regulation and expression. Many of these methods, however, have limited in vivo potential for clinical gene therapy because they compromise …
- 210000004185 Liver 0 title abstract description 35
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
- A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Frese Jr et al. | Targeting of genes to the liver with glycoprotein carriers | |
Perales et al. | An evaluation of receptor‐mediated gene transfer using synthetic DNA‐ligand complexes | |
Guy et al. | Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy | |
Boeckle et al. | Melittin analogs with high lytic activity at endosomal pH enhance transfection with purified targeted PEI polyplexes | |
Plank et al. | Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand | |
Erbacher et al. | Glycosylated polylysine/DNA complexes: gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size | |
Merwin et al. | Targeted delivery of DNA using YEE (GalNAcAH) 3, a synthetic glycopeptide ligand for the asialoglycoprotein receptor | |
CA2012311C (en) | New protein-polycation-conjugate | |
Kircheis et al. | Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery | |
US6177554B1 (en) | Nucleic acid transporter systems | |
US5166320A (en) | Carrier system and method for the introduction of genes into mammalian cells | |
Li et al. | Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody | |
US5994109A (en) | Nucleic acid transporter system and methods of use | |
CA2103371C (en) | Targeted delivery of genes encoding secretory proteins | |
Boeckle et al. | Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems | |
AU683400B2 (en) | Use of a bacterial component to enhance targeted delivery of polynucleotides to cells | |
Han et al. | Specific gene transfer mediated by galactosylated poly-L-lysine into hepatoma cells | |
Niidome et al. | Gene transfer into hepatoma cells mediated by galactose-modified α-helical peptides | |
Rojanasakul et al. | Targeted gene delivery to alveolar macrophages via Fc receptor-mediated endocytosis | |
WO1994006923A1 (en) | Modification of a virus to redirect infectivity and enhance targeted delivery of polynucleotides to cells | |
Koyo et al. | Effect of electric charge on the hepatic uptake of macromolecules in the rat liver | |
Mustapa et al. | Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell | |
Deshpande et al. | Receptor-mediated peptide delivery in pulmonary epithelial monolayers | |
Fabre et al. | Synthetic peptides as non-viral DNA vectors | |
Chiou et al. | In vivo gene therapy via receptor-mediated dna delivery |